In a recent study published in the Clinical Epigenetics entitled
"Characterization of DNA methylation changes in EBF3 and TBC1D16
associated with tumor progression and metastasis in multiple cancer
types," scientists from the University of Otago have identified a variety
of cancer cell biomarkers that may help clinicians identify which cancer cells
are more likely to spread to other parts of the body.
The results of this study may provide
clinicians and patients with more clear ideas to elucidate the mechanism of
cancer cell spread and how to use effective therapies for the treatment of
different types of cancer at a later stage. Early detection of the rate of
cancer spread may help improve the prognosis of cancer patients, said
researcher Euan Rodger.
In most patients who die of cancer, the spread of cancer from one organ to another is often considered highly lethal, and tracking the spread of cancer has become an important weapon against cancer. In the study, researchers wanted to see if new molecular changes existed in other types of cancer cells, albeit with some confusion, but in general, the researchers got the answers they wanted.
Based on the results of this study, the researchers are expected to develop novel strategies to track the therapeutic effects of cancer patients in the future; next, researchers will also continue to conduct in-depth studies to find more epigenetic markers to reveal the mechanisms of progression and metastasis of many types of cancer.
In most patients who die of cancer, the spread of cancer from one organ to another is often considered highly lethal, and tracking the spread of cancer has become an important weapon against cancer. In the study, researchers wanted to see if new molecular changes existed in other types of cancer cells, albeit with some confusion, but in general, the researchers got the answers they wanted.
Based on the results of this study, the researchers are expected to develop novel strategies to track the therapeutic effects of cancer patients in the future; next, researchers will also continue to conduct in-depth studies to find more epigenetic markers to reveal the mechanisms of progression and metastasis of many types of cancer.
